Fundraising FoxCota Capital — 2020 Investments
5 investments dated 2020 · listed companies and verified rows first · show all
Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT.
AI & Machine LearningHealthtechMedical DevicesSeattle, US
Gabriel Jones(Co-founder & CEO)inSamuel Browd(Co-founder)inJoshua Smith(Co-founder)inJames Youngquist(Co-founder)in
Co-investorsBold Capital PartnersDCVC (Data Collective)Bird B. AGHTCPresence CapitalBOLD Longevity+4 more
CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams.
BiotechDeep TechHardwareMedical DevicesAtlanta, US
Alla Zamarayeva(CEO & Co-founder)inTodd Sulchek, PhD(CSO & Co-founder)Alex Alexeev, PhD(Co-founder)Todd Sulchek(CSO & Co-founder)inAlex Alexeev(Co-founder)in
Co-investorsDynamk CapitalCreative Destruction Lab (CDL)Elm Street VenturesEmbark VenturesGreatPoint VenturesM Ventures+1 more
Correlia Bio develops the PIXI platform, a benchtop automated immunoassay system that uses proprietary microfluidic gel technology to quantify proteins from samples as small as 1 uL.
BiotechDeep TechHardwareHealthtechMedical DevicesSan Francisco, US
Akwasi Apori(Founder)inKursad Araz(Founder)inSamuel Tia(Founder)in
Co-investorsBeresford VenturesBlue Bear VenturesEndurance28Pallasite VenturesPangaea Ventures Us Inc.SV Latam Capital+13 more
PuraCath Medical develops disinfection technology for catheter connections designed to reduce infection risk in healthcare settings.
BiotechHealthtechMedical DevicesSilicon Valley, US
Julia Rasooly(CEO)in
Co-investorsGeekdomRising TideStartXTransPacific Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Global Processing Services
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.